Research Analysts’ Weekly Ratings Updates for Cognex (CGNX)

Several analysts have recently updated their ratings and price targets for Cognex (NASDAQ: CGNX):

  • 8/3/2022 – Cognex had its price target lowered by analysts at Cowen Inc. from $75.00 to $55.00. They now have an “outperform” rating on the stock.
  • 8/3/2022 – Cognex was upgraded by analysts at Sanford C. Bernstein from a “market perform” rating to an “outperform” rating. They now have a $65.00 price target on the stock.
  • 8/3/2022 – Cognex had its price target lowered by analysts at Cowen Inc from $75.00 to $55.00. They now have a “maintains” rating on the stock.
  • 8/3/2022 – Cognex had its “maintains” rating reaffirmed by analysts at Raymond James.
  • 8/3/2022 – Cognex had its “maintains” rating reaffirmed by analysts at Needham & Company LLC.
  • 8/3/2022 – Cognex was downgraded by analysts at Stephens from an “overweight” rating to an “equal weight” rating. They now have a $45.00 price target on the stock, down previously from $80.00.
  • 8/1/2022 – Cognex had its price target lowered by analysts at Needham & Company LLC from $80.00 to $60.00. They now have a “buy” rating on the stock.
  • 6/23/2022 – Cognex had its price target lowered by analysts at The Goldman Sachs Group, Inc. from $59.00 to $41.00. They now have a “sell” rating on the stock.
  • 6/9/2022 – Cognex had its price target lowered by analysts at Raymond James from $90.00 to $80.00.

Cognex Stock Performance

CGNX stock opened at $46.46 on Thursday. The firm has a fifty day moving average price of $46.03 and a 200 day moving average price of $58.87. Cognex Co. has a fifty-two week low of $41.69 and a fifty-two week high of $92.17. The firm has a market cap of $8.07 billion, a PE ratio of 29.97 and a beta of 1.66.

Cognex (NASDAQ:CGNXGet Rating) last posted its quarterly earnings data on Tuesday, August 2nd. The scientific and technical instruments company reported $0.41 EPS for the quarter, topping the consensus estimate of $0.36 by $0.05. Cognex had a net margin of 25.67% and a return on equity of 19.48%. During the same quarter last year, the business earned $0.43 earnings per share. On average, equities analysts predict that Cognex Co. will post 1.52 EPS for the current year.

Insiders Place Their Bets

In other news, Director Dianne M. Parrotte acquired 3,000 shares of the company’s stock in a transaction on Thursday, May 12th. The stock was bought at an average cost of $46.00 per share, with a total value of $138,000.00. Following the completion of the purchase, the director now directly owns 3,608 shares of the company’s stock, valued at $165,968. The purchase was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. 4.10% of the stock is owned by insiders.

Institutional Trading of Cognex

Several institutional investors and hedge funds have recently made changes to their positions in CGNX. National Bank of Canada FI bought a new stake in shares of Cognex during the fourth quarter worth $93,000. State of New Jersey Common Pension Fund D raised its holdings in shares of Cognex by 1.8% in the fourth quarter. State of New Jersey Common Pension Fund D now owns 104,010 shares of the scientific and technical instruments company’s stock valued at $8,088,000 after acquiring an additional 1,830 shares in the last quarter. CWM LLC bought a new stake in shares of Cognex in the fourth quarter valued at about $131,000. Raymond James Trust N.A. raised its holdings in shares of Cognex by 4.3% in the fourth quarter. Raymond James Trust N.A. now owns 4,342 shares of the scientific and technical instruments company’s stock valued at $338,000 after acquiring an additional 178 shares in the last quarter. Finally, Centaurus Financial Inc. raised its holdings in shares of Cognex by 72.4% in the fourth quarter. Centaurus Financial Inc. now owns 8,325 shares of the scientific and technical instruments company’s stock valued at $647,000 after acquiring an additional 3,496 shares in the last quarter. 88.85% of the stock is currently owned by institutional investors.

Cognex Corporation provides machine vision products that capture and analyze visual information in order to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, aspirin bottles, and automobile tires by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.

Featured Stories

Want More Great Investing Ideas?

Receive News & Ratings for Cognex Co Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex Co and related companies with MarketBeat.com's FREE daily email newsletter.